Skip to content

NIELS GRAINDOR

Active Private limited companyfounded 2017active for 9 yearsWitbornstraat 11, 3404 LandenKBO/BCE: BE 0680.444.805 #3 company by equity in Landen, Health and social work sector

Lifetime

8 annual accounts with figures on one time axis
peak of €493,184 in 2025
€493,184▲ 25.9%
peak of €370,280 in 2025
€370,280▲ 28.8%
peak of €1.2m in 2025
€1.2m▲ 36.6%
€53,704▼ 13.9%
Board1 name since 2017
1 director
Documentsfilings and deeds
25-08-202625 days late
2025micro format
Gross margin from €391,750 to €493,184Result from €287,473 to €370,280Dividend €60,000Equity from €848,441 to €1.2m

Key points

from the 2025 annual accounts

Equity

€1.2m ▲ 36.6%

NIELS GRAINDOR has made a profit in every financial year since 2018.

Turnover

≈ €720,000 estimated

The accounts state no turnover.

Liquidity

22.57 was 14.02 in 2024

Short-term debts fell from €60,210 to €51,697.

Filings

8 annual accounts 5 late
AprilJune31 JulyOctober20202025

The 2024 accounts came in latest, 26 days after the end of the period.

Position in the sector

€370,280

Higher net result than 95% of companies in human health. The sector median is €59,520, over 21,355 companies.

Checked score

Bankruptcy probability within 12 months

Financial strength

Score breakdown

Comparable companies, two years later

In July 2024, 6,785 companies had the same profile as NIELS GRAINDOR has now. Each dot stands for 17 companies, two years later.

96.7%
were still trading
2.7%
stopped another way
0.6%
went bankrupt
  • Small
  • 5 to 10 years old
  • solvency 30% or more
  • a profit of 5% of the balance sheet or more
Test of the method

The method was tested on the 497,965 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 0.9%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.8%
9 2.9% 3.1%
10 5.6% 6.1%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 6,785 companies, not a prediction for NIELS GRAINDOR. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Credit verdict

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Board and ownership

Director, since 25-08-2017
  • 186 sharesdeed of 29-08-2017

Shares in 1 company,

Board & ownership

Recent changes

Registered in the Peppol Directory Reachable for e-invoices through 0208:0680444805
changes role from manager to director Discharge granted to · General meeting of 22-11-2023 · Gazette deed
Incorporation appointed as manager · Founded by · Founding capital of €18,600, 186 shares · published on 29-08-2017 · Gazette deed
First establishment Witbornstraat 11, Landen
All 18 events

Comparable companies

same main activity, similar in size and age
Company
NIELS GRAINDOR Landen €1.2m €493,184 95.6% -
Dr. Ruben Claeys, Radiologie Liedekerke €1.0m €470,231 66.0% 0.8
NEOSTRIATUM Knokke-Heist €1.0m €475,823 96.9% -
Dr. M. DEVOOGHDT, RADIOLOOG Ninove €1.6m €481,851 37.4% 2.7
AVEO Radiologie Oud-Turnhout €1.2m €592,070 37.6% 1.6
Dr. Bruno Deboeck Roosdaal €1.1m €353,285 35.7% -
GOFFINET JS Arlon €1.0m €301,133 97.4% -

These companies have the same main activity as NIELS GRAINDOR: medical imaging and medical laboratories (NACE 86910). They are comparable in size and age: total assets between €1m and €1.6m, founded between 2015 and 2019.

Official details

Source: KBO
Status
Active since 25-08-2017Normal situation
Activity
Medical imaging and medical laboratoriesNACE 86910and 1 other
Establishment unit
2.267.059.9473404 Landen, since 25-08-2017
Financial year end
31 December
Peppol
Reachable since 30-10-2025
Company details

Annual accounts 2025

€1.2m▲ 33.1%
Filing
Filed on 25-08-2026
Financials

Insights on NIELS GRAINDOR

NIELS GRAINDOR files the micro format. That format states no turnover. The gross margin rose from €93,841 in 2018 to €493,184 in 2025.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about NIELS GRAINDOR

What is the company number of NIELS GRAINDOR?
The company number of NIELS GRAINDOR is 0680.444.805. The VAT number is the same number with BE in front: BE 0680.444.805.
Where is NIELS GRAINDOR based?
The registered office is at Witbornstraat 11, 3404 Landen.Company details
What does NIELS GRAINDOR do?
According to the KBO register, the main activity is medical imaging and medical laboratories (NACE 86910).
What is the legal form of NIELS GRAINDOR?
NIELS GRAINDOR is a private limited company (BV).
When was NIELS GRAINDOR founded?
NIELS GRAINDOR was founded on 25-08-2017.
Is NIELS GRAINDOR still active?
Yes, NIELS GRAINDOR is an active enterprise in the KBO register.
What is the turnover of NIELS GRAINDOR?
The turnover in financial year 2025 is about €720,000. This figure is estimated from the gross margin of €493,184 and 48 comparable companies (NACE 86). It probably lies between €600,000 and €920,000.Financials
Is NIELS GRAINDOR profitable?
In financial year 2025, NIELS GRAINDOR made a profit of €370,280.
Where can I find the annual accounts of NIELS GRAINDOR?
NIELS GRAINDOR filed 8 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of NIELS GRAINDOR due?
NIELS GRAINDOR must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.